Comparison of methods for the detection of Mycoplasmal contamination of cell cultures: a review.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 1092606)

Published in In Vitro on July 28, 1975

Authors

E L Schneider, E J Stanbridge

Articles by these authors

A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res (1988) 17.88

Oligonucleotide probes complementary to variable regions of ribosomal RNA discriminate between Mycoplasma species. J Gen Microbiol (1987) 4.74

Incorporation of 3H-uridine and 3H-uracil into RNA: a simple technique for the detection of mycoplasma contamination of cultured cells. Exp Cell Res (1974) 3.73

The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A (1976) 3.21

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86

Synthetic oligonucleotide probes complementary to rRNA for group- and species-specific detection of mycoplasmas. Isr J Med Sci (1987) 2.76

Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science (1987) 2.52

Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene (1994) 2.45

Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A (1998) 2.20

Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16

Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J (1986) 2.11

Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science (1990) 2.07

Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04

Aging, natural death, and the compression of morbidity: another view. N Engl J Med (1983) 1.98

Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res (1997) 1.96

Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Science (1974) 1.95

Cloned mycoplasma ribosomal RNA genes for the detection of mycoplasma contamination in tissue cultures. Science (1984) 1.92

Purification and partial characterization of the principal deoxyribonucleic acid polymerase from Mycoplasmatales. J Bacteriol (1977) 1.88

Life extension. N Engl J Med (1985) 1.83

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A (2001) 1.81

Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol (1990) 1.80

Infectious diseases in the elderly. Ann Intern Med (1983) 1.76

Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol (1994) 1.69

Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62

Suppression of malignancy in human cells. Nature (1976) 1.59

c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res (1990) 1.59

Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res (2001) 1.55

Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem Biophys Res Commun (1989) 1.54

Decreased expression of heat shock protein 70 mRNA and protein after heat treatment in cells of aged rats. Proc Natl Acad Sci U S A (1990) 1.51

Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene (1991) 1.45

Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet (1981) 1.44

Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Res (2000) 1.43

Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol (1985) 1.43

The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells. Nucleic Acids Res (1991) 1.37

Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum. Nature (1969) 1.36

Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene (1994) 1.35

Mycoplasma contamination of cultured amniotic fluid cells: potential hazard to prenatal chromosomal diagnosis. Science (1974) 1.32

Severe pulmonary involvement in adult Gaucher's disease. Report of three cases and review of the literature. Am J Med (1977) 1.31

Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene (2011) 1.31

Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane. Proc Natl Acad Sci U S A (1987) 1.27

Colony size distributions as a measure of in vivo and in vitro aging. Proc Natl Acad Sci U S A (1978) 1.27

DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A (1996) 1.22

Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom (2006) 1.20

Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ (1991) 1.19

Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency. Cancer Res (1984) 1.19

Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev (1996) 1.19

Increased nuclear sizes in senescent human diploid fibroblast cultures. Exp Cell Res (1976) 1.17

Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest (1988) 1.16

Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci U S A (1986) 1.16

Measurement of DNA content and cell volume in senescent human fibroblasts utilizing flow multiparameter single cell analysis. Exp Cell Res (1976) 1.15

Mycoplasma detection-an obligation to scientific accuracy. Isr J Med Sci (1981) 1.14

Diseases and disorders of aging: an hypothesis. J Chronic Dis (1986) 1.14

Geriatrics and gerontology: imperatives in education and training. Ann Intern Med (1986) 1.14

Anchorage-independent growth of normal human fibroblasts. Proc Natl Acad Sci U S A (1981) 1.13

A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics (1997) 1.12

In utero diagnosis of Niemann-Pick disease. Am J Hum Genet (1971) 1.12

Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci U S A (1998) 1.12

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci U S A (1999) 1.11

A DNA probe, D5 [D4S90] mapping to human chromosome 4p16.3. Nucleic Acids Res (1988) 1.11

Projecting the older population of the United States: lessons from the past and prospects for the future. Milbank Q (1988) 1.10

A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell (1981) 1.09

Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. Science (1991) 1.09

DNA damage and repair with age in individual human lymphocytes. Mutat Res (1990) 1.09

Abundant alkali-sensitive sites in DNA of human and mouse sperm. Exp Cell Res (1989) 1.08

Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res (1992) 1.08

Mycoplasma capping on lymphocytes. Nature (1978) 1.07

Functional complementation of ataxia-telangiectasia group D (AT-D) cells by microcell-mediated chromosome transfer and mapping of the AT-D locus to the region 11q22-23. Proc Natl Acad Sci U S A (1991) 1.07

Tissue-specific differences in cultured human diploid fibroblasts. Exp Cell Res (1977) 1.07

Appearance of hypoxanthine guanine phosphoribosyltransferase activity as a consequence of mycoplasma contamination. Nature (1975) 1.07

Modifications of alkaline microgel electrophoresis for sensitive detection of DNA damage. Int J Radiat Biol (1994) 1.07

Relationship between cell replication and volume in senescent human diploid fibroblasts. Mech Ageing Dev (1976) 1.06

Replication rate and lifespan of cultured fibroblasts in Down's syndrome. Proc Soc Exp Biol Med (1972) 1.06

Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids. Cancer Res (1986) 1.06

Modification of amino-acid concentrations induced by mycoplasmas in cell culture medium. Nat New Biol (1971) 1.05

Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene (2006) 1.05

A case for human tumor-suppressor genes. Bioessays (1985) 1.05

Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids. Cell (1978) 1.04

p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int J Cancer (2000) 1.04

Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc Natl Acad Sci U S A (1996) 1.03

A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat Res (1991) 1.03

Lip pits and congenital absence of second premolars: varied expression of the Lip Pits syndrome. J Med Genet (1973) 1.02

In utero diagnosis of globoid cell leukodystrophy (Krabb's disease). Biochem Biophys Res Commun (1971) 1.02

Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J Med Genet (2003) 1.02

Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybrids. Cytogenet Cell Genet (1980) 1.02

Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene (2011) 1.01

A reevaluation of the role of mycoplasmas in human disease. Annu Rev Microbiol (1976) 1.00

The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth. Oncogene (1995) 1.00

In vivo analysis of cellular replication. Proc Natl Acad Sci U S A (1977) 1.00

Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene (2001) 1.00

RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis. J Natl Cancer Inst (2001) 0.99

Comparative analysis of mycoplasma ribosomal RNA operons. Isr J Med Sci (1984) 0.99

Assembly of the QM protein onto the 60S ribosomal subunit occurs in the cytoplasm. J Cell Biochem (1998) 0.99

Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080. Genes Chromosomes Cancer (1994) 0.97

Dissociation of anchorage independence form tumorigenicity in human cell hybrids. Int J Cancer (1980) 0.97

Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells. Am J Hum Genet (1989) 0.96

Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. Proc Natl Acad Sci U S A (1978) 0.96